AbbVie Statistics

Total Valuation

AbbVie has a market cap or net worth of CAD 463.99 billion. The enterprise value is 554.66 billion.

Market Cap	463.99B
Enterprise Value	554.66B

Important Dates

The last earnings date was Friday, April 25, 2025.

Earnings Date	Apr 25, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.03%
Shares Change (QoQ)	+0.17%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.77B

Valuation Ratios

The trailing PE ratio is 77.69 and the forward PE ratio is 14.74.

PE Ratio	77.69
Forward PE	14.74
PS Ratio	5.63
PB Ratio	220.80
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.32, with an EV/FCF ratio of 25.08.

EV / Earnings	92.87
EV / Sales	6.92
EV / EBITDA	14.32
EV / EBIT	20.88
EV / FCF	25.08

Financial Position

The company has a current ratio of 0.76, with a Debt / Equity ratio of 47.90.

Current Ratio	0.76
Quick Ratio	0.48
Debt / Equity	47.90
Debt / EBITDA	2.53
Debt / FCF	4.55
Interest Coverage	6.68

Financial Efficiency

Return on equity (ROE) is 88.40% and return on invested capital (ROIC) is 15.45%.

Return on Equity (ROE)	88.40%
Return on Assets (ROA)	8.34%
Return on Invested Capital (ROIC)	15.45%
Return on Capital Employed (ROCE)	19.06%
Revenue Per Employee	1.50M
Profits Per Employee	108,585
Employee Count	55,000
Asset Turnover	0.40
Inventory Turnover	3.79

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +16.60% in the last 52 weeks. The beta is 0.54, so AbbVie's price volatility has been lower than the market average.

Beta (5Y)	0.54
52-Week Price Change	+16.60%
50-Day Moving Average	28.04
200-Day Moving Average	27.35
Relative Strength Index (RSI)	49.13
Average Volume (20 Days)	11,979

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.48

Income Statement

In the last 12 months, AbbVie had revenue of CAD 82.46 billion and earned 5.97 billion in profits. Earnings per share was 3.36.

Revenue	82.46B
Gross Profit	58.56B
Operating Income	27.33B
Pretax Income	5.21B
Net Income	5.97B
EBITDA	39.33B
EBIT	27.33B
Earnings Per Share (EPS)	3.36

Full Income Statement

Balance Sheet

The company has 7.44 billion in cash and 100.65 billion in debt, giving a net cash position of -93.21 billion.

Cash & Cash Equivalents	7.44B
Total Debt	100.65B
Net Cash	-93.21B
Net Cash Per Share	n/a
Equity (Book Value)	2.10B
Book Value Per Share	1.16
Working Capital	-12.55B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 23.57 billion and capital expenditures -1.46 billion, giving a free cash flow of 22.11 billion.

Operating Cash Flow	23.57B
Capital Expenditures	-1.46B
Free Cash Flow	22.11B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 71.01%, with operating and profit margins of 33.15% and 7.31%.

Gross Margin	71.01%
Operating Margin	33.15%
Pretax Margin	6.31%
Profit Margin	7.31%
EBITDA Margin	47.70%
EBIT Margin	33.15%
FCF Margin	26.82%

Dividends & Yields

AbbVie does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	266.46%
Buyback Yield	-0.03%
Shareholder Yield	-0.03%
Earnings Yield	1.29%
FCF Yield	4.77%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AbbVie has an Altman Z-Score of 2.14. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.14
Piotroski F-Score	n/a